Mattel Reiterates FY23 Guidance

2023 Guidance Mattel's full year 2023 guidance remains: (in millions,    

2023 Guidance

Mattel’s full year 2023 guidance remains:

(in millions,  

 

   

except EPS and percentages)

 

FY2023 Guidance

 

FY2022

Net Sales  

Comparable

(Constant Currency)

 

$5,435

Adjusted Gross Margin  

~ 47%

 

45.9%

Adjusted EPS  

$1.10 – $1.20

 

$1.25

Adjusted EBITDA  

$900 – $950

 

$968

Adjusted Tax Rate  

25 – 26%

 

24%

Capital Expenditures  

$175 – $200

 

$187

Free Cash Flow  

> $400

 

$256

Total
0
Shares
Related Posts
Read More

Reported Late Wednesday March 08, GIO World Health Announces Plans To Go Public Via Business Combination With Apeiron Capital Investment; Will Be Listed On Either The NYSE Or NASDAQ, And Will Be Renamed “Gio World Health Holdings, Inc.”

GIO World Health Ltd ("GIO World Health") has entered into a business combination agreement with Apeiron Capital Investment Corp (APNC). The post-closing combined public company, which will be named GIO

APNC